Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
Clinical trial NCT01890759 · COMPLETED
Trial details
- NCT number
- NCT01890759
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-25
- Primary completion
- 2016-04-12
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.